Azienda Sanitaria Locale Della Provincia Di Lecce

Lecce 8 trials 2 recruiting

8 Registered trials

2 Currently recruiting

Organisation

Azienda Sanitaria Locale Della Provincia Di Lecce

Location

Lecce, Italy

Identifier

ORG-100048821

Address

Via Antonio Miglietta 5, 73100, Italy

Departments

ASL e Polimabulatorio
Dipartimento di Salute Mentale
Ematologia-A.O. “Cardinale G.Panico” -Tricase
Medical oncology
Nuclear Medicine
Oncologia Medica
Radiotherapy
U.O.C. Ematologia

Clinical trials at this site (8)

Search interface

Stereotactic body radiation therapy on Prostate with or without Androgen deprivation therapy, a phase III randomized controlled trial (SPA T… Pending

2024-520093-34-00 Acinar cell prostatic carcinoma 5
Use of the diagnostic PET with 64CuCl2 in order to select patients, in which a disease relapse is shown after prostate surgical removal, to … Pending

2025-520868-17-00 Cancer on the prostatic bed 5
Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants from Approximately 2 Months of Age Recruiting

2023-507600-32-00 Pneumococcal Immunization 5 2025-05-22
Phase III study in mCRC patients with RAS/BRAF wild type tissue and RAS/BRAF mutated in LIquid BIopsy to compare in first-line therapy FOLFI… Recruiting

2024-517863-22-00 Study population consists in patients with a diagnosis 5 2024-12-01
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Subjects With Progressive Metastatic Castration-… Ended

2024-513968-25-00 Metastatic castration-resistant prostate cancer (mCRPC) 5 2025-04-28
A study to evaluate if aticaprant added to a current antidepressant and given up to one year is safe and would help improve depression. Ended

2023-508163-74-00 Major Depressive Disorder 5 2023-06-12
A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Ri… Ended

2023-504036-17-00 Chronic Lymphocytic Leukemia (CLL) 5 2020-05-07
Multicenter trial with carfilzomib combined with lenalidomide or cyclophopshamide with or without autologous transplant in newly diagnosed m… Ended

2024-516630-35-01 NEWLY DIAGNOSED MULTIPLE MYELOMA (MM) PATIENTS ELEGIBLE 4 2015-01-12